XML 41 R30.htm IDEA: XBRL DOCUMENT
v3.25.2

EARNINGS PER SHARE (Tables) | 6 Months Ended
--- | ---
Jun. 30, 2025
Earnings Per Share [Abstract] |
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share | The table below sets forth the share-based awards that have been excluded from the computation of diluted earnings per share because their effect would be anti-dilutive:
| For the Three Months Ended June 30, |  | For the Six Months Ended June 30,
| 2025 |  | 2024 |  | 2025 |  | 2024
Anti-Dilutive Options | — |  |  | 1,187,492 |  |  | — |  |  | 1,187,492 |
Anti-Dilutive Restricted Stock Units | 272,463 |  |  | 2,106,007 |  |  | 263,930 |  |  | 2,106,007 |
Anti-Dilutive Performance Share Units | — |  |  | 1,010,251 |  |  | — |  |  | 1,010,251 |
| 272,463 |  |  | 4,303,750 |  |  | 263,930 |  |  | 4,303,750 |
The table below sets forth the potential common shares issuable upon conversion of the Convertible Notes that were excluded from the calculation of diluted earnings per share because their effect would be anti-dilutive:
| For the Three Months Ended June 30, |  | For the Six Months Ended June 30,
| 2025 |  | 2024 |  | 2025 |  | 2024
Convertible Notes | — |  |  | 25,751,869 |  |  | — |  |  | 25,751,869 |
Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity | The table below sets forth the share-based awards that have been exercised or released:
| For the Three Months Ended June 30, |  | For the Six Months Ended June 30,
| 2025 |  | 2024 |  | 2025 |  | 2024
Options | 15,999 |  |  | 97,999 |  |  | 98,006 |  |  | 909,436 |
Restricted Stock Units | 98,695 |  |  | 18,436 |  |  | 731,083 |  |  | 846,212 |
Performance Share Units | — |  |  | — |  |  | 483,570 |  |  | 753,673 |
| 114,694 |  |  | 116,435 |  |  | 1,312,659 |  |  | 2,509,321 |
Schedule of Earnings Per Share, Basic and Diluted | The computations for basic and diluted earnings per share are as follows:
| For the Three Months Ended June 30, |  | For the Six Months Ended June 30,
| 2025 |  | 2024 |  | 2025 |  | 2024
Net Income (Loss) | $ | 432,521 |  |  | $ | (18,261) |  |  | $ | 234,806 |  |  | $ | (11,410) |
Basic Earnings (Loss) Available to Shareholders | $ | 432,521 |  |  | $ | (18,261) |  |  | $ | 234,806 |  |  | $ | (11,410) |
Effect of Dilutive Securities: |  |  |  |  |  |  |
Add Back Interest on Convertible Notes (Net of Tax) | $ | 1,396 |  |  | $ | — |  |  | $ | 2,791 |  |  | $ | — |
Diluted Earnings (Loss) Available to Shareholders | $ | 433,917 |  |  | $ | (18,261) |  |  | $ | 237,597 |  |  | $ | (11,410) |
Weighted-Average Shares of Common Stock Outstanding | 143,429,950 |  |  | 152,608,500 |  |  | 145,592,034 |  |  | 152,986,576 |
Effect of Diluted Shares:* |  |  |  |  |  |  |
Options | 569,960 |  |  | — |  |  | 578,015 |  |  | — |
Restricted Stock Units | 1,148,725 |  |  | — |  |  | 1,127,351 |  |  | — |
Performance Share Units | 846,092 |  |  | — |  |  | 851,337 |  |  | — |
Convertible Notes | 25,751,869 |  |  | — |  |  | 25,751,869 |  |  | — |
Weighted-Average Diluted Shares of Common Stock Outstanding | 171,746,596 |  |  | 152,608,500 |  |  | 173,900,606 |  |  | 152,986,576 |
Earnings (Loss) per Share: |  |  |  |  |  |  |
Basic | $ | 3.02 |  |  | $ | (0.12) |  |  | $ | 1.61 |  |  | $ | (0.07) |
Diluted | $ | 2.53 |  |  | $ | (0.12) |  |  | $ | 1.37 |  |  | $ | (0.07) |
*During periods in which the Company incurs a net loss, diluted weighted average shares outstanding are equal to basic weighted average shares outstanding because the effect of all equity awards and the potential share settlement impact related to CNX’s Convertible Notes are antidilutive.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration